US11028102B2ActiveUtilityPatentIndex 59
Methods of using 1-O-acetylbritannilatone spiro aryl isoxazoline compounds
Assignee: XIAN TAIKOMED PHARMACEUTICAL TECH CO LTDPriority: Dec 15, 2017Filed: Feb 29, 2020Granted: Jun 8, 2021
Est. expiryDec 15, 2037(~11.5 yrs left)· nominal 20-yr term from priority
A61P 11/06C07D 498/10C07D 495/04A61P 29/00
59
PatentIndex Score
0
Cited by
0
References
2
Claims
Abstract
A method of inhibiting leukotriene include: administrating a therapeutically effective amount of a compound of chemical formula I or II or a pharmaceutical acceptable salt thereof to a subject,R1 is OH or OAc; X is C or N; and R2 is H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO2, or halogen, provided that when X is N, R2 is nil.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of inhibiting leukotriene comprising:
administrating a therapeutically effective amount of a compound of chemical formula I or II or a pharmaceutical acceptable salt thereof to a subject,
wherein R 1 is OH or OAc; X is C or N; and R 2 is H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO 2 , or halogen, provided that when X is N, R 2 is nil.
2. The method of claim 1 , wherein X is C and R 2 is H, F, Cl, Br, CN, CH 3 , OCH 3 , NO 2 or OH.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.